Description
ICLUSIG is a prescription medicine used to treat adults who have:
- Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
- in combination with chemotherapy in newly diagnosed Ph+ ALL*
- alone in adults with Ph+ ALL who cannot receive any other kinase inhibitor medicines or who have a specific type of abnormal gene (T315I-positive) Ph+ ALL
- Chronic Myeloid Leukemia (CML)
- chronic phase CML who did not tolerate or no longer benefit from treatment with at least 2 prior kinase inhibitor medicines
- accelerated phase or blast phase CML who cannot receive any other kinase inhibitor medicines
- a specific type of abnormal gene (T315I-positive) chronic phase, accelerated phase, or blast phase CML
Additional information
| Brand | ICLUSIG® 15mg |
|---|---|
| Generic name | Ponatinib tablets |
| Form | Oral tablets |
| Strength | 15mg |
| Packing | 30's |
| Manufacturer | Takeda Pharmaceuticals |
| Documents | Either PO or prescription |
| Storage | Below 25°C |
| Global delivery time | 10-15 days |
| Pay attention | Shipment should be organized from our Company with airlines only (Not FedEx, DHL, EMS, Aramex, UPS), at the specified storage condition along with one data logger. |
Reviews
There are no reviews yet.